Naho Yakuwa, BPharm

Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development, Tokyo, Japan; Social Pharmacy and Regulatory Science, Showa Pharmaceutical University, Tokyo, Japan; Corresponding author: Naho Yakuwa, BPharm, National Center for Child Health and Development, Japan Drug Information Institute in Pregnancy, Okura 2-10-1, Setagaya-ku, Tokyo, Japan 1578535 ([email protected]).

Reply to Perugula et al: Toward Improving Reliability of Safety Information on Drug Exposure in Pregnancy

Letter to the Editor

Reply to Perugula et al: Toward Improving Reliability of Safety Information on Drug Exposure in Pregnancy

November 30, 2022

Naho Yakuwa, BPharm, responds to Perugula and colleagues about a recent study on SGA use during early pregnancy.

Naho Yakuwa

Pregnancy Outcomes With First-Trimester SGA Exposure

Original Research

Pregnancy Outcomes With First-Trimester SGA Exposure

June 8, 2022

In Japan, information regarding the effects of antipsychotics on the fetus during pregnancy is limited. This Japanese study examined the association between the use of antipsychotics during pregnancy and...

Naho Yakuwa, Kunihiko Takahashi, Tatsuhiko Anzai, et al